Russia approves experiments on a Chinese vaccine to prevent corona


 


Russia has granted approval to conduct clinical trials of a Chinese vaccine to prevent COVID-19, which is AD5NCove, with the participation of 8,000 volunteers, Interfax news agency reported Monday.


This vaccine was developed by the Chinese company Cansino Biology in cooperation with a research unit supported by the Chinese military.


And the Russian TASS agency had revealed that the Russian government had added the Corona vaccine to the list of vital and basic medicines, after the Russian Ministry of Health set the maximum cost price for the fifth Sputnik virus vaccine at 1942 rubles for two doses (about 26.20 dollars), according to Alexei Kuznetsov, Assistant to the Russian Minister of Health, and said that "the Russian Ministry of Health has recorded the maximum price for a vaccine product to prevent infection with the new Corona virus" Sputnik v ", which was developed by the Gamalya National Center for Epidemiology and Microbiology Research, and it is 1942 rubles for two doses

Commentaires